Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High Resolution Maps of the HeLa 3D Genome Using Hi-C

ABSTRACT:

PROVIDER: phs001010 | dbGaP |

SECONDARY ACCESSION(S): PRJNA299709PRJNA299708

REPOSITORIES: dbGaP

ACCESS DATA

Json Xml

Similar Datasets

HeLa Cell Genome Sequencing Studies

Project description:<p>This study contains all authorized whole genome sequence data of the HeLa cell line from datasets currently in dbGaP. These data have been approved for health, medical, and/or biomedical research purposes. Access to these data can be granted for one year. Accessible data will include the studies listed on this page and any additional authorized datasets that become available during this one-year period.</p> <p><a href="http://acd.od.nih.gov/hlgda.htm">The HeLa Genome Data Access Working Group of the Advisory Committee to the Director (ACD)</a> will review requests from the research community for access to these datasets and assess whether the requests align with the terms of use defined in the HeLa Genome Data Use Agreement. The Working Group's findings will be reported to the ACD, and the ACD will make recommendations to the NIH Director about whether a request should be approved or disapproved. The NIH Director will decide whether access to the data will be granted.</p>

| phs000640.v1.p1 | EGA

Improving Human Genome Annotation Using a High-Stringency Proteogenomics Workflow

Project description:Reanalysis of three large human tissue proteomics datasets using a bespoke GENCODE database and multiOTHER algorithm high confidence pipeline.

2016-05-27 | PXD002967 | Pride

The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line.

Project description: Not available

| S-EPMC3740412 | biostudies-literature

High-quality genome (re)assembly using chromosomal contact data.

Project description: Not available

| S-EPMC4284522 | biostudies-literature

Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs.

Project description: Not available

| S-EPMC3912166 | biostudies-literature

Whole genome miRNA expression profiling using HeLa cells in response to Heat shock stress.

Project description:Exiqon miRNA array contains LNA-modified oligos which minimizes the Tm-range within which probe hybridizes with the transcript in query, thus minimizing the mis-match. Taking advantage of this, we used the miRCURY LNA array to investigate genome wide signatures for miRNA expression in response to heat shock stress. We also did mRNA expression profiling using the same RNA to look for possible miRNA-mRNA interaction in response to heat shock stress. For the differentially expressed miRNAs, target predictions were done using both miRanda and TargetScan. The consensus set was used for subsequent experimental validation.

2015-01-01 | GSE60472 | GEO

Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide micorarray

Project description:Human LATS1 and LATS2 (LATS1/2) are tumor suppressors that have been shown to be mutated or downregulated in several human cancers including leukemia, lung, prostate and breast cancers. However, the precise mechanisms and the proteins modulated by LATS1/2 that are responsible for these events remain largely unknown. To elucidate potential signaling pathways, the current study investigated the expression profile in HeLa cells with reduced expression of LATS1/2. Using RNA-mediated intereference, both LATS1 and LATS2 were substantially knocked-down, and accordingly, this lead to an increase in multiple phenotypes associated with tumor progression, including enhanced cell proliferation, resistance to drug-induced cell death, and increase cell migration. Using whole human genome oligo (60-mer) arrays (Agilent), gene modulated by loss of LATS1/2 were identified and functionally grouped into categories including cell proliferation, cell death, cell adhesion and motility, as well as cell communication. Selected genes, including known tumor suppressor genes and oncogenes such as CDKN1A, WISP2, SLIT2, TP53INP1, BIRC4BP, SPRY2, SPRY4, SPRED1, FAT4,and CYR61 were confirmed by qRT-PCR to be significantly differentially expressed. Importantly, the collection of genes identified suggests that LATS1/2 functions through diverse mechanisms and multiple signaling pathways including the Hippo signaling pathway, as well as the p53, Ras-ERK, or WNT networks, in inhibit tumor progression.

2009-09-17 | GSE18138 | GEO

Construction of miRNA-target networks using microRNA profiles of CVB3-infected HeLa cells.

Project description: Not available

| S-EPMC6884461 | biostudies-literature

In vivo genome editing using a high-efficiency TALEN system.

Project description: Not available

| S-EPMC3491146 | biostudies-literature

Using high-resolution variant frequencies to empower clinical genome interpretation.

Project description: Not available

| S-EPMC5563454 | biostudies-literature